Clinical trial
Effects of Fatty Acid Supplementation on Substance Dependent Individuals
NCT00312455 · National Institute on Drug Abuse (NIDA), NIH · Completed
Key facts
| NCT number | NCT00312455 |
|---|---|
| Title | Effects of Fatty Acid Supplementation on Substance Dependent Individuals |
| Official title | Cholesterol and Fatty Acids in Cocaine Addiction Relapse |
| Lead sponsor | National Institute on Drug Abuse (NIDA), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Substance-related Disorders |
| Intervention type | Drug |
| Interventions | Pro-eicosapentaenoic acid (EPA), Pro-docosapentaenoic acid (DPA), Placebo |
| Start date | Jul 1, 2004 |
| Primary completion | Jul 1, 2005 |
| Completion | Jul 1, 2005 |
| First posted | Apr 10, 2006 |
| Last update posted | Jan 12, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: